Federal government’s consultation on pharmacare solicits Canadians’ feedback
In June 2018, the federal government established an Advisory Council on the Implementation of National Pharmacare to get Canadians’ feedback on what a national drug program should look like. This consultation, which closed on September 28, included an online discussion forum and a questionnaire.
The Unifor Health Care Council focused on encouraging all Unifor members and their families to take the online questionnaire and support the idea of a universal pharmacare program. Members were asked to share their feedback on what national pharmacare can and should look like and Unifor continued to promote a national pharmacare program on social media and through our networks and coalitions.
Unifor industry councils also heard about the consultation at this year’s Canadian Council and members could easily take action through the Unifor mobile app. Early in September, members from coast to coast to coast received a letter from the National President’s office, calling on them to add their voice in support of universal prescription drug coverage. In addition to this, subscribers of our weekly e-newsletter, Unilink, also received reminders to join in the online discussion.
This consultation was a significant milestone in lobbying for a national drug plan. We know that Canadians need pharmacare to provide comprehensive coverage and fair access to prescription medication for everyone. In particular, we have made it clear that what we need is universal prescription, and not a patchwork system that may subject Canadians to demeaning means-testing to determine eligibility.
Now that the consultation is wrapped up, a report-back is expected, which will be posted at www.canada.ca/pharmacare. Updates will be shared by Unifor on Facebook and Twitter, through our weekly online newsletter, Unilink and in future editions of The Pulse.